Clinical trial
Biologic Correlative Taxotere/AC
NCT00206466 · Baylor Breast Care Center, Other · Completed
Key facts
| NCT number | NCT00206466 |
|---|---|
| Title | Biologic Correlative Taxotere/AC |
| Official title | A Randomized Multicenter Trial of Neoadjuvant Taxotere and Adriamycin/Cytoxan(AC): A Biologic Correlative Study |
| Acronym | TAX/AC |
| Lead sponsor | Baylor Breast Care Center, Other |
| Collaborators | Baylor College of Medicine |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Taxotere, Adriamycin/cytoxan |
| Enrollment | 70 |
| Start date | Apr 1, 2002 |
| Primary completion | Apr 1, 2006 |
| Completion | Jan 1, 2012 |
| First posted | Sep 21, 2005 |
| Last update posted | Jan 25, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: